These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31471386)

  • 1. A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.
    Cho E; Cho HA; Jun CH; Kim HJ; Cho SB; Choi SK
    In Vivo; 2019; 33(5):1411-1420. PubMed ID: 31471386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
    Hung AK; Guy J
    World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection.
    Kinoshita A; Koike K; Nishino H
    Geriatr Gerontol Int; 2017 Feb; 17(2):189-201. PubMed ID: 26847184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?
    Chu KKW; Chok KSH
    World J Gastroenterol; 2019 Jul; 25(27):3563-3571. PubMed ID: 31367157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future Frontiers.
    Grieb BC; Goff LW; Goyal L; Denlinger CS
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():248-260. PubMed ID: 31099615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of hepatocellular carcinoma.
    El-Serag HB; Marrero JA; Rudolph L; Reddy KR
    Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Prajapati HJ; Kim HS
    PLoS One; 2017; 12(2):e0170750. PubMed ID: 28170405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
    Zhao Y; Li H; Bai W; Liu J; Lv W; Sahu S; Guan S; Qin X; Wang W; Ren W; Mu W; Guo W; Gu S; Ma Y; Yin Z; Guo W; Wang W; Wang Y; Duran R; Fan D; Zhang Z; Han G
    Int J Cancer; 2016 Aug; 139(4):928-37. PubMed ID: 27038145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular Carcinoma: therapeutic options 2015].
    Schultheiß M; Bettinger D; Neeff HP; Brunner TB; Thimme R
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1063-8. PubMed ID: 26182255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma.
    Solaini L; Cucchetti A; Piccino M; Gardini A; La Barba G; Serenari M; Cescon M; Ercolani G
    Future Oncol; 2019 Feb; 15(4):439-449. PubMed ID: 30620230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.